Nektar Therapeutics
NKTR
NKTR
212 hedge funds and large institutions have $376M invested in Nektar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $561M → $376M (-$185M)
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
Holders
212
Holding in Top 10
–
Calls
$48K
Puts
$33K
Top Buyers
| 1 | +$3.46M | |
| 2 | +$2.3M | |
| 3 | +$2.04M | |
| 4 |
BlackRock
New York
|
+$1.99M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.53M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$1.73M | |
| 3 | -$1.73M | |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$1.65M |
| 5 |
Morgan Stanley
New York
|
-$1.49M |